Skip to main content

Main menu

  • Home
  • Current issue
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis

Miriam J. Johnson, Lucy Close, Suzie C. Gillon, Alex Molassiotis, Paul H. Lee, Morag C. Farquhar on behalf of the Breathlessness Research Interest Group (BRIG)
European Respiratory Journal 2016 47: 1861-1864; DOI: 10.1183/13993003.02089-2015
Miriam J. Johnson
1Hull York Medical School, University of Hull, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: miriam.johnson@hyms.ac.uk
Lucy Close
2Lindsey Lodge Hospice, Scunthorpe, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzie C. Gillon
3Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Molassiotis
4School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul H. Lee
4School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morag C. Farquhar
5Primary Care Unit, Dept of Public Health and Primary Care, University of Cambridge, Institute of Public Health, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Measuring chronic dyspnoea in clinical studies: numerical rating scale better than the modified Borg scale http://ow.ly/XZc1G

To the Editor:

The subjective nature of the experience of chronic breathlessness (dyspnoea) creates challenges for patients who need to communicate its intensity, and for clinicians and researchers who need to measure the symptom in order to plan management and assess the effect of interventions.

The numerical rating scale (NRS) [1] and modified Borg scale (mBorg) [2] are recommended measures for breathlessness [3]. However, their use has extended beyond their initial validation. NRS scales using different time frames (“now” and “average”) have been validated [1, 4, 5], but not for the mBorg. Further, participants might have a preference for mBorg scores with associated verbal descriptors.

Our objective was to investigate whether: 1) there is a response bias against using mBorg numerical ratings that lack categorical labels; 2) the timeframe (average per 24 h, “worst”, “now” or “at rest”) of the mBorg or NRS effects participants’ assessment; 3) mBorg and NRS scores are correlated

This was a secondary analysis of pooled data from 1048 participants (510 men, 396 women and 142 gender data unavailable; diagnoses: cancer 223 (21.3%), heart failure 200 (19%) and non-malignant lung disease 617 (59%)) with breathlessness due to a variety of causes from 10 studies of people where mBorg, at least, was measured. Where both mBorg and NRS were measured, these were concurrent. All studies used the same version of the Borg; a variant of the Borg Category-Ratio scale with a maximum value of 10, and with verbal descriptors missing for values six and eight.

Most contributing studies are described more fully elsewhere [6–13] but are summarised here as follows. 1) Quantifiable data from a primarily qualitative study (study 1: n=47; mean age 69 years (range 46–92 years)) that measured mBorg (average 24 h, worst, rest, nonspecific now and exertion) with NRS for seven participants [7]. 2) Two phase III trials: the first (study 2: n=35; mean (range) age 70 years (41–89 years)) measured mBorg and NRS (average 24 h, worst, rest, nonspecific now and exertion) [9]; the second (study 3: n=154; mean (range) age 71 years (28–91 years)) measured mBorg and NRS (rest and exertion) [11]. 3) Two feasibility studies: one (study 4: n=46; mean (range) age 69.5 years (62–73 years)) measured mBorg and NRS (rest) [6]; the other (study 5: n=13; mean (range) age 67 years (53–80 years)) measured mBorg only (rest and exertion) [12]. 4) Five observational studies: study 6 (n=50; mean (range) age 69 years (42–83 years)) measured mBorg only (pre- and post-exertion) [8]; study 7 (n=109; mean (range) age 65 years (38–52 years)) measured mBorg only (now) [10]; study 8 (n=99) measured mBorg only (average over previous 24 h) (Farida Malik, St Wilfrids Hospice, Eastbourne and East Sussex Healthcare NHS, UK; personal communication); study 9 (n=353; mean (range) age 65 years (24–90 years)) measured mBorg only (average and worst over previous 24 h) [13]; and study 10 (n=142; mean (range) age 69 years (34–91 years)) measured mBorg and NRS (average, worst over past 24 h and now) (Patrick White, King's College London, London,  UK; personal communication). Proxy scores were excluded.

The individual distributions of mBorg and NRS scores (average, worst, now, rest and exertion) were visualised with predicted values using truncated Poisson distribution with their corresponding mean plotted as a reference. Descriptive statistics including mean, standard deviation and frequency were examined. The strength of association between mBorg and the corresponding NRS was examined using two-way mixed intraclass correlation (consistency).

The frequency of mBorg scores for numbers six and eight (no verbal descriptor) was less than expected. There were also fewer than expected measures for 0.5 (verbal descriptor of “Very very weak (just noticeable)”). In general, scores for mean averages over 24 h were normally distributed for mBorg (other than the pattern noted above) and NRS. However, no NRS “average” scores exceeded eight. Although an NRS score of seven is considered “severe”, equivalent to an mBorg of five, mBorg “average” scores included a maximum of 10 (figure 1).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Modified Borg scale (mBorg) and numerical rating scale (NRS) scores in relation to the perception of breathlessness a) now (mBorg n=368; NRS n=108), b) at rest (mBorg n=261; NRS n=60), c) during exertion (mBorg n=261, NRS n=23), d) on average over the past 24 h (mBorg n=498; NRS n=86), and e) at worst over the past 24 h (mBorg n=559; NRS n=106). Histograms show predicted truncated Poisson probabilities.

The pattern of scores for “worst” NRS and mBorg per 24 h was similar although, as expected given the equivalent severity scores, there were more high NRS scores.

For point in time measures, the patterns for “exertion” mBorg and NRS were similar, with few mild scores. Conversely, mBorg “at rest” and “now” scores and NRS “at rest” scores shared a similar pattern, but with very few severe scores. However, the NRS “now” scores had measures across the response spectrum, including very severe scores.

The strongest association between NRS (n=21; mean±sd 7.23±1.80) and mBorg (n=261; mean±sd 5.55±2.18) was for “on exertion” (intracluster correlation (ICC)=0.66, 95% CI 0.33–0.85), and the weakest was for “now” (NRS n=106, mean±sd 4.51±2.72; mBorg n=368, mean±sd 2.36±1.79; ICC=0.14, 95% CI −0.05–0.33). ICC (95% CI) for the other associations were: “average” 0.51 (0.15–0.75); “worst” 0.55 (0.34–0.71) and “rest” 0.33 (−0.09–0.66).

Our data indicate preferential reporting of mBorg scores with descriptors. This may be due to the mBorg's stem question: “Choose a number whose words best describe…”. A less than predicted level of use of 0.5, despite a descriptor, suggests that “very very weak” is either indistinguishable in the context of chronic breathlessness or “0.5” is not understood; the visual analogue scale may be more sensitive in reporting breathlessness due to light intensity work [14].

Aside from the observed reduction in non-descriptor mBorg scores, the pattern of mBorg and NRS scores in relation to the previous 24 h appears to be as expected, apart from a possible ceiling with the NRS. The observed pattern of responses for NRS “now” probably reflects the contemporaneous context. For example a patient waiting in the clinic room for some time will respond differently to one who has hurried into the clinic. Thus, unless the measure is taken with close definition of the circumstances of “now”, responses will be difficult to interpret.

Despite the numerical discrepancy between the two scales, the intracluster correlations were moderate for “on exertion” and “average”, albeit with wide confidence intervals, suggesting that the mBorg might be used to assess intensity of breathlessness on average or over the past 24 h. The mBorg and NRS “now” were poorly correlated, presumably for the reasons outlined above. It should be noted that with some ICC calculations there is a large discrepancy between the smaller and larger number. Therefore, the ICCs should be interpreted with caution because the missing data cannot be assumed to be missing at random.

These data suggest that there is a participant response bias against using numerical ratings that lack categorical labels, in which case, the scale would “lose” the ratio properties that Borg wanted to preserve. Therefore, we recommend that, given the non-controlled conditions in chronic breathlessness clinical studies, the NRS is used. Reported mBorg values may differ if the stem is simplified to “choose a number to describe…”.

The NRS “at rest” and “on exertion” appear useful as “point in time” measures. However, the circumstances of “now” should be stipulated. Given the possible ceiling for “average” NRS scores the mBorg (average over 24 h) may be preferable in populations with severe daily breathlessness.

The analysis of this pooled data from people with chronic breathlessness suggests that there is a response bias in favour of mBorg responses with a verbal descriptor. The theoretical advantages of the mBorg scale under known and scalable stimulus conditions (e.g. in pulmonary rehabilitation programmes or cardiopulmonary exercise testing) therefore are not necessarily maintained in less controlled clinical studies. A change in the mBorg stem question should be considered and tested. The NRS scale should be used in preference, except for people with very severe breathlessness. The context of “point in time” measures should be clearly stated on completion of measurements.

Acknowledgements

With thanks to members of the Breathlessness Research Interest Group who provided data: Claudia Bausewein (University of Munich, Munich, Germany); Saskie Dorman (Poole Hospital NHS Foundation Trust, Poole, UK); Morag Farquhar and Sara Booth (University of Cambridge, Cambridge, UK); Alex Molassiotis (The Hong Kong Polytechnic University, Hong Kong); Stephen Oxberry (Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, UK); Farida Malik (Eastbourne and East Sussex Healthcare NHS Trust, Eastbourne, UK); Steffen Simon (University of Cologne, Cologne, Germany); Kyle Pattinson (University of Oxford, Oxford, UK); Janelle Yorke (University of Manchester, Manchester, UK); Patrick White (King's College London, London, UK).

Footnotes

  • Conflict of interest: None declared.

  • Received December 10, 2015.
  • Accepted January 24, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Gift AG,
    2. Narsavage G
    . Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998; 7: 200–204.
    OpenUrlAbstract
  2. ↵
    1. Muza SR,
    2. Silverman MT,
    3. Gilmore GC, et al.
    Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 909–913.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Bausewein C,
    2. Farquhar M,
    3. Booth S, et al.
    Measurement of breathlessness in advanced disease: a systematic review. Respir Med 2007; 101: 399–410.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Gift AG
    . Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs 1989; 14: 323–325.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Wilcock A,
    2. Crosby V,
    3. Clarke D, et al.
    Repeatability of breathlessness measurements in cancer patients. Thorax 1999; 54: 375.
    OpenUrlPubMedWeb of Science
  6. ↵
    1. Molassiotis A,
    2. Charalambous A,
    3. Taylor P, et al.
    The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Support Care Cancer 2015; 23: 1637–1645.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Simon ST,
    2. Higginson IJ,
    3. Benalia H, et al.
    Episodic and continuous breathlessness: a new categorization of breathlessness. J Pain Symptom Manage 2013; 45: 1019–1029.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Herigstad M,
    2. Hayen A,
    3. Evans E, et al.
    Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest 2015; 148: 953–961.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Oxberry SG,
    2. Torgerson DJ,
    3. Bland JM, et al.
    Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial. Eur J Heart Fail 2011; 13: 1006–1012.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Bausewein C,
    2. Booth S,
    3. Gysels M, et al.
    Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010; 13: 1109–1118.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Farquhar MC,
    2. Prevost A,
    3. McCrone P, et al.
    Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med 2014; 12: 194.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Farquhar MC,
    2. Higginson IJ,
    3. Fagan P, et al.
    The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. BMC Palliat Care 2009; 8: 9.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Yorke J,
    2. Moosavi SH,
    3. Shuldham C, et al.
    Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65: 21–26.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Adams L,
    2. Lane R,
    3. Shea SA, et al.
    Breathlessness during different forms of ventilatory stimulation: a study of mechanisms in normal subjects and respiratory patients. Clin Sci (Lond) 1985; 69: 663–672.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
View this article with LENS
Vol 47 Issue 6 Table of Contents
European Respiratory Journal: 47 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis
Miriam J. Johnson, Lucy Close, Suzie C. Gillon, Alex Molassiotis, Paul H. Lee, Morag C. Farquhar
European Respiratory Journal Jun 2016, 47 (6) 1861-1864; DOI: 10.1183/13993003.02089-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis
Miriam J. Johnson, Lucy Close, Suzie C. Gillon, Alex Molassiotis, Paul H. Lee, Morag C. Farquhar
European Respiratory Journal Jun 2016, 47 (6) 1861-1864; DOI: 10.1183/13993003.02089-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Prednisolone plus itraconazole in acute-stage ABPA complicating asthma
  • Identification of prevalent TB disease through screening in migrants
  • Prednisolone plus itraconazole in acute-stage ABPA complicating asthma
Show more Agora

Research letters

  • Prednisolone plus itraconazole in acute-stage ABPA complicating asthma
  • Identification of prevalent TB disease through screening in migrants
  • Prednisolone plus itraconazole in acute-stage ABPA complicating asthma
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society